ELEVANCE HEALTH INCEE

ELEVANCE HEALTH INC

8,031.13MXND
+74.13+0.93%
At close at Feb 28, 19:55 GMT
MXN
No trades
See on Supercharts

ELV fundamentals

Key facts

Market capitalization‪1.86 T‬MXN
Founded1944
Employees (FY)‪104.2 K‬
CEOGail Koziara Boudreaux
About

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Ownership
‪‪227.35 M‬‬
Free Float shares
‪‪226.94 M‬‬ (99.82%)
Closely held shares
‪‪413.55 K‬‬ (0.18%)
Free Float shares
‪‪226.94 M‬‬ (99.82%)
Closely held shares
‪‪413.55 K‬‬ (0.18%)
Capital structure
Market cap
‪‪1.86 T‬‬
Debt
‪‪668.08 B‬‬
Minority interest
‪‪2.31 B‬‬
Enterprise value
‪‪2.53 T‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.86 T‬‬
Price to earning ratio (P/E)
15.09x
Price to sales ratio (P/S)
0.51x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
15.09x
Price to sales ratio (P/S)
0.51x
Valuation ratios
‪0.00‬
‪0.20‬
‪0.40‬
‪0.60‬
‪0.80‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪5.00‬
‪10.00‬
‪15.00‬
‪20.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪0.9%‬
‪2.0%‬
‪3.1%‬
‪4.2%‬
‪5.3%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪250.00 B‬‬
‪‪500.00 B‬‬
‪‪750.00 B‬‬
‪‪1.00 T‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
Total operating expenses
Op income
Non-operating income
Pretax income
Taxes & Other
Net income
‪0.00‬
‪‪250.00 B‬‬
‪‪500.00 B‬‬
‪‪750.00 B‬‬
‪‪1.00 T‬‬
Revenue
Total operating expenses
Op income
Expenses & adjustments
Net income
‪0.00‬
‪‪250.00 B‬‬
‪‪500.00 B‬‬
‪‪750.00 B‬‬
‪‪1.00 T‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Health Benefits
CarelonRx
Carelon Services
Reconciling Items
Corporate and Other
By country
Period: 2024
United States

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪250.00 B‬‬
‪‪500.00 B‬‬
‪‪750.00 B‬‬
‪‪1.00 T‬‬
Actual
Estimate
Earnings
Next:Apr 16, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪60.00‬
‪120.00‬
‪180.00‬
‪240.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
25.46%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
1.64%
Next payment
35.211
Next ex-date
Mar 10, 2025
Dividend history
‪0.95%‬
‪1.16%‬
‪1.37%‬
‪1.58%‬
‪1.79%‬
2020
2021
2022
2023
2024
‪0.00‬
‪35.00‬
‪70.00‬
‪105.00‬
‪140.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Insurance reserves, claims and premiums
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪200.00 B‬‬
‪‪400.00 B‬‬
‪‪600.00 B‬‬
‪‪800.00 B‬‬
Insurance reserves
Policy claims
Premium earned
Capital allocation analysis
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.30‬
‪0.60‬
‪0.90‬
‪1.20‬
Reserve to total capital
Unearned premium to total capital